Anti-Tumor Immunity Induced by IRE of Unresectable Pancreatic Cancer

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 1, 2015

Primary Completion Date

December 1, 2020

Study Completion Date

May 1, 2021

Conditions
Pancreatic Cancer
Interventions
DEVICE

NanoKnife LEDC System

Irreversible electroporation (IRE) is a new, minimal-invasive image-guided treatment method for tumors not amenable for surgical resection or thermal ablation, due to vicinity near vital structures such as vessels and bile ducts. With IRE, multiple electrical pulses are applied to tumorous tissue. These pulses alter the existing transmembrane potential of the cell membranes, and create 'nanopores', after which the cell dies through loss of homeostasis.

Trial Locations (1)

510665

FUDA Cancer Hospital, Guangzhou

All Listed Sponsors
lead

Fuda Cancer Hospital, Guangzhou

OTHER

NCT02343835 - Anti-Tumor Immunity Induced by IRE of Unresectable Pancreatic Cancer | Biotech Hunter | Biotech Hunter